Matthieu Lafaurie
-
- Antibiotic Use and Resistance 8
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 11
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 8
- Antimicrobial Resistance in Staphylococcus 6
- Virology top 5%
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 9
- Urinary Tract Infections Management 7
-
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Neutropenia and Cancer Infections 7
- Co-authors
- Jean‐Michel MolinaRaphaël PorcherD. SéréniA. BourgaritD DrozFrank MartinezAndré FurcoAlexandre Karras
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Matthieu Lafaurie
60 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 101
- Applied Microbiology and Biotechnology 184
- Molecular Medicine 295
- Infectious Diseases 766
- Virology 149
- Epidemiology 748
Countries citing papers authored by Matthieu Lafaurie
This map shows the geographic impact of Matthieu Lafaurie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Lafaurie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Lafaurie more than expected).
Fields of papers citing papers by Matthieu Lafaurie
This network shows the impact of papers produced by Matthieu Lafaurie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Lafaurie. The network helps show where Matthieu Lafaurie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthieu Lafaurie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 36 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 9 | |
| 9 | 2017 | 11 | |
| 10 | 2016 | 19 | |
| 11 | 2015 | 2 | |
| 12 | 2014 | 25 | |
| 13 | 2014 | 12 | |
| 14 | 2012 | 87 | |
| 15 | 2012 | 14 | |
| 16 | 2010 | 4 | |
| 17 | 2009 | 85 | |
| 18 | 2009 | 7 | |
| 19 | 2003 | 279 | |
| 20 | 2001 | 9 |
About Matthieu Lafaurie
Matthieu Lafaurie is a scholar working on Applied Microbiology and Biotechnology, Microbiology and Molecular Medicine, having authored 64 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (9 papers), Antifungal resistance and susceptibility (8 papers), Antibiotic Use and Resistance (8 papers), Urinary Tract Infections Management (7 papers), Neutropenia and Cancer Infections (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (184 citations), Molecular Medicine (295 citations) and Infectious Diseases (766 citations). Matthieu Lafaurie has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Jean‐Michel Molina, Raphaël Porcher, D. Séréni, A. Bourgarit, D Droz, Frank Martinez, André Furco, Alexandre Karras, Christophe Legendre and Jean‐Luc Donay.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.